Clinical Lymphoma, Myeloma & Leukemia最新文献

筛选
英文 中文
OA-43 Interim Results of a Phase 2 Trial of Isatuximab-Lenalidomide for Patients with High-Risk Smoldering Multiple Myeloma 伊沙妥昔单抗-来那度胺治疗高危烟雾型多发性骨髓瘤患者2期试验的OA-43中期结果
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2024-09-01 DOI: 10.1016/S2152-2650(24)01884-6
Sheeba Thomas, Elisabet Manasanch, Neha Korde, Hans Lee, Sundar Jagannath, Melody Becnel, Gregory Kaufman, Krina Patel, Swaminathan Iyer, Sham Mailankody, Donna Weber, Zuzana Lutter-Berka, Shawnee Carpenter, David Berrios Nolasco, Michelle Hildebrandt, Lei Feng, Behrang Amini, Sattva Neelapu, Robert Orlowski, Ola Landgren
{"title":"OA-43 Interim Results of a Phase 2 Trial of Isatuximab-Lenalidomide for Patients with High-Risk Smoldering Multiple Myeloma","authors":"Sheeba Thomas, Elisabet Manasanch, Neha Korde, Hans Lee, Sundar Jagannath, Melody Becnel, Gregory Kaufman, Krina Patel, Swaminathan Iyer, Sham Mailankody, Donna Weber, Zuzana Lutter-Berka, Shawnee Carpenter, David Berrios Nolasco, Michelle Hildebrandt, Lei Feng, Behrang Amini, Sattva Neelapu, Robert Orlowski, Ola Landgren","doi":"10.1016/S2152-2650(24)01884-6","DOIUrl":"10.1016/S2152-2650(24)01884-6","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Page S27"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
OA-44 Frontline Systemic Treatment Outcomes in POEMS Syndrome – Analysis from the UCLH POEMS Centre Registry Spanning 25 Years OA-44 POEMS 综合征的前线系统治疗结果--来自 UCLH POEMS 中心长达 25 年的登记分析
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2024-09-01 DOI: 10.1016/S2152-2650(24)01885-8
Oliver Tomkins, Jahanzaib Khwaja, Michael Lunn, Ryan Keh, Stephen Keddie, Shirley D'Sa, Jonathan Sive
{"title":"OA-44 Frontline Systemic Treatment Outcomes in POEMS Syndrome – Analysis from the UCLH POEMS Centre Registry Spanning 25 Years","authors":"Oliver Tomkins, Jahanzaib Khwaja, Michael Lunn, Ryan Keh, Stephen Keddie, Shirley D'Sa, Jonathan Sive","doi":"10.1016/S2152-2650(24)01885-8","DOIUrl":"10.1016/S2152-2650(24)01885-8","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Pages S27-S28"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
P-021 A German Multicenter Real-World Analysis of Talquetamab in 102 Patients With Relapsed/Refractory Multiple Myeloma P-021 Talquetamab 在 102 例复发性/难治性多发性骨髓瘤患者中的德国多中心实际应用分析
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2024-09-01 DOI: 10.1016/S2152-2650(24)01924-4
Jan Frenking, Christine Riedhammer, Britta Besemer, Jan Braune, Annamaria Brioli, Franziska Brunner, Maria Dampmann, Deniz Gezer, Sarah Goldman-Mazur, Mathias Hänel, Christine Hanoun, Marion Högner, Katja Kolditz, Igor Kos, Miriam Kull, Theo Leitner, Maximilan Merz, Ivana von Metzler, Christian S. Michel, Raphael Teipel, Marc-Steffen Raab
{"title":"P-021 A German Multicenter Real-World Analysis of Talquetamab in 102 Patients With Relapsed/Refractory Multiple Myeloma","authors":"Jan Frenking, Christine Riedhammer, Britta Besemer, Jan Braune, Annamaria Brioli, Franziska Brunner, Maria Dampmann, Deniz Gezer, Sarah Goldman-Mazur, Mathias Hänel, Christine Hanoun, Marion Högner, Katja Kolditz, Igor Kos, Miriam Kull, Theo Leitner, Maximilan Merz, Ivana von Metzler, Christian S. Michel, Raphael Teipel, Marc-Steffen Raab","doi":"10.1016/S2152-2650(24)01924-4","DOIUrl":"10.1016/S2152-2650(24)01924-4","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Pages S52-S53"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
OA-34 HBI0101, an Anti-BCMA Chimeric Antigen Receptor T-Cell (CART) for Relapsed/Refractory Multiple Myeloma 治疗复发性/难治性多发性骨髓瘤的抗 BCMA 嵌合抗原受体 T 细胞 (CART) OA-34 HBI0101
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2024-09-01 DOI: 10.1016/S2152-2650(24)01875-5
Eyal Lebel, Nathalie Asherie, Shlomit kfir-Erenfeld, Sigal Grisariu, Batia Avni, Shlomo Elias, Miri Assayag, Tali Dubnikov-Sharon, Eran Zimran, Adir Shaulov, marjorie Pick, Cyrille Cohen, Polina Stepensky, Moshe Gatt
{"title":"OA-34 HBI0101, an Anti-BCMA Chimeric Antigen Receptor T-Cell (CART) for Relapsed/Refractory Multiple Myeloma","authors":"Eyal Lebel, Nathalie Asherie, Shlomit kfir-Erenfeld, Sigal Grisariu, Batia Avni, Shlomo Elias, Miri Assayag, Tali Dubnikov-Sharon, Eran Zimran, Adir Shaulov, marjorie Pick, Cyrille Cohen, Polina Stepensky, Moshe Gatt","doi":"10.1016/S2152-2650(24)01875-5","DOIUrl":"10.1016/S2152-2650(24)01875-5","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Page S22"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142311889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
OA-36 METTL14 Enhances Multiple Myeloma Progression via m6A RNA Methylation-Mediated Regulation of TRAF6 Translation OA-36 METTL14通过m6A RNA甲基化介导的TRAF6翻译调控促进多发性骨髓瘤进展
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2024-09-01 DOI: 10.1016/S2152-2650(24)01877-9
Liping Zuo, Zhixin Li, Linyu Cai, Aoshuang Xu, Qun Li, Chunyan Sun
{"title":"OA-36 METTL14 Enhances Multiple Myeloma Progression via m6A RNA Methylation-Mediated Regulation of TRAF6 Translation","authors":"Liping Zuo, Zhixin Li, Linyu Cai, Aoshuang Xu, Qun Li, Chunyan Sun","doi":"10.1016/S2152-2650(24)01877-9","DOIUrl":"10.1016/S2152-2650(24)01877-9","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Page S23"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142311891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
OA-53 Isa-KRd in High-Risk Newly Diagnosed Multiple Myeloma – 4-Year-Follow-Up from the GMMG-CONCEPT trial OA-53 Isa-KRd 在高风险新诊断多发性骨髓瘤中的应用--GMMG-CONCEPT 试验的 4 年随访结果
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2024-09-01 DOI: 10.1016/S2152-2650(24)01894-9
Lisa Leypoldt, Britta Besemer, Mathias Hänel, Marc-Steffen Raab, Christoph Mann, Christian S. Michel, Hans Christian Reinhardt, Igor Wolfgang Blau, Martin Görner, Yon-Dschun Ko, Maike de Wit, Hans Salwender, Christof Scheid, Ullrich Graeven, Rudolf Peceny, Peter Staib, Annette Dieing, Hermann Einsele, Anna Jauch, Michael Hundemer, Katja Weisel
{"title":"OA-53 Isa-KRd in High-Risk Newly Diagnosed Multiple Myeloma – 4-Year-Follow-Up from the GMMG-CONCEPT trial","authors":"Lisa Leypoldt, Britta Besemer, Mathias Hänel, Marc-Steffen Raab, Christoph Mann, Christian S. Michel, Hans Christian Reinhardt, Igor Wolfgang Blau, Martin Görner, Yon-Dschun Ko, Maike de Wit, Hans Salwender, Christof Scheid, Ullrich Graeven, Rudolf Peceny, Peter Staib, Annette Dieing, Hermann Einsele, Anna Jauch, Michael Hundemer, Katja Weisel","doi":"10.1016/S2152-2650(24)01894-9","DOIUrl":"10.1016/S2152-2650(24)01894-9","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Pages S33-S34"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142309743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
P-001 Impact of Age and Frailty on Outcomes of Patients with Multiple Myeloma Receiving CAR T-Cell Therapies – A Single Center Experience P-001 年龄和体弱对接受 CAR T 细胞疗法的多发性骨髓瘤患者预后的影响--单中心经验
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2024-09-01 DOI: 10.1016/S2152-2650(24)01904-9
Nadine Abdallah, Mohammed Elhaj, Supriya Gupta, Matthew Rees, Suheil Albert Atallah-Yunes, Terri Menser, Radhika Bansal, Gavin Schaeferle, Camille Knepper, Rahma Warsame, Wilson Gonsalves, Prashant Kapoor, Francis Buadi, Suzanne Hayman, Yi Lin, Shaji Kumar
{"title":"P-001 Impact of Age and Frailty on Outcomes of Patients with Multiple Myeloma Receiving CAR T-Cell Therapies – A Single Center Experience","authors":"Nadine Abdallah, Mohammed Elhaj, Supriya Gupta, Matthew Rees, Suheil Albert Atallah-Yunes, Terri Menser, Radhika Bansal, Gavin Schaeferle, Camille Knepper, Rahma Warsame, Wilson Gonsalves, Prashant Kapoor, Francis Buadi, Suzanne Hayman, Yi Lin, Shaji Kumar","doi":"10.1016/S2152-2650(24)01904-9","DOIUrl":"10.1016/S2152-2650(24)01904-9","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Page S40"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142312247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
P-003 Determinants of Response to Anti-CD38 and Bispecific Combination Therapy in Patients with Relapsed/Refractory Multiple Myeloma P-003 多发性骨髓瘤复发/难治患者对抗CD38和双特异性联合疗法反应的决定因素
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2024-09-01 DOI: 10.1016/S2152-2650(24)01906-2
Adolfo Aleman, Ariel Kogan Zajdman, Tarek Mouhieddine, Bhaskar Upadhyaya, Oliver Van Oekelen, Alessandro Lagana, Leah Grossman, Santiago Thibaud, Larysa Sanchez, Shambavi Richard, Adriana Rossi, Joshua Richter, Hearn Jay Cho, Cesar Rodriguez-Valdes, Ajai Chari, Samir Parekh
{"title":"P-003 Determinants of Response to Anti-CD38 and Bispecific Combination Therapy in Patients with Relapsed/Refractory Multiple Myeloma","authors":"Adolfo Aleman, Ariel Kogan Zajdman, Tarek Mouhieddine, Bhaskar Upadhyaya, Oliver Van Oekelen, Alessandro Lagana, Leah Grossman, Santiago Thibaud, Larysa Sanchez, Shambavi Richard, Adriana Rossi, Joshua Richter, Hearn Jay Cho, Cesar Rodriguez-Valdes, Ajai Chari, Samir Parekh","doi":"10.1016/S2152-2650(24)01906-2","DOIUrl":"10.1016/S2152-2650(24)01906-2","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Page S41"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142312249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
OA-61 All Oral Triplet Iberdomide Ixazomib and Dexamethasone in Elderly Patients With Multiple Myeloma Patients at First Relapse: Results of the IFM Phase 2 Study I2D OA-61 全口服三联伊贝多米-伊沙佐米和地塞米松治疗首次复发的老年多发性骨髓瘤患者:IFM 2 期研究 I2D 的结果
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2024-09-01 DOI: 10.1016/S2152-2650(24)01902-5
Cyrille Touzeau, Xavier Leleu, Mourad Tiab, Margaret Macro, Aurore Perrot, Julie Gay, Carine Chateleix, Murielle Roussel, Lionel Karlin, Caroline Jacquet, Salomon Manier, Cyrille Hulin, Olivier Decaux, Valentine Richez, Thomas Chalopin, Mohamad Mohty, Frederique Orsini-Piocelle, Denis Caillot, Cécile Sonntag, Hervé Avet-Loiseau, Philippe Moreau
{"title":"OA-61 All Oral Triplet Iberdomide Ixazomib and Dexamethasone in Elderly Patients With Multiple Myeloma Patients at First Relapse: Results of the IFM Phase 2 Study I2D","authors":"Cyrille Touzeau, Xavier Leleu, Mourad Tiab, Margaret Macro, Aurore Perrot, Julie Gay, Carine Chateleix, Murielle Roussel, Lionel Karlin, Caroline Jacquet, Salomon Manier, Cyrille Hulin, Olivier Decaux, Valentine Richez, Thomas Chalopin, Mohamad Mohty, Frederique Orsini-Piocelle, Denis Caillot, Cécile Sonntag, Hervé Avet-Loiseau, Philippe Moreau","doi":"10.1016/S2152-2650(24)01902-5","DOIUrl":"10.1016/S2152-2650(24)01902-5","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Pages S38-S39"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
OA-19 Marrow Immune Features Are Most Informative of Early MRD Negative Treatment Response in Newly Diagnosed TE Patients: Insights from the UKMRA Phase 3 RADAR Study OA-19 骨髓免疫特征对新诊断的 TE 患者的早期 MRD 阴性治疗反应最有参考价值:UKMRA第3期RADAR研究的启示
IF 2.7 4区 医学
Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2024-09-01 DOI: 10.1016/S2152-2650(24)01860-3
Dipal Mehta, Stephen Henderson, Jasmin Rahman, Emma Lyon, Elise Rees, Kane Foster, Daria Galas-Filipowicz, Catherine Olivier, Lorna Barnard, Kara-Louise Royle, Robert Cicero, Doina Levinte, Jonathan Clemmens, Ruth De Tute, Christopher Parrish, Mark Drayson, Ceri Bygrave, Dean Smith, Jonathan Sive, Guy Pratt, Kwee Yong
{"title":"OA-19 Marrow Immune Features Are Most Informative of Early MRD Negative Treatment Response in Newly Diagnosed TE Patients: Insights from the UKMRA Phase 3 RADAR Study","authors":"Dipal Mehta, Stephen Henderson, Jasmin Rahman, Emma Lyon, Elise Rees, Kane Foster, Daria Galas-Filipowicz, Catherine Olivier, Lorna Barnard, Kara-Louise Royle, Robert Cicero, Doina Levinte, Jonathan Clemmens, Ruth De Tute, Christopher Parrish, Mark Drayson, Ceri Bygrave, Dean Smith, Jonathan Sive, Guy Pratt, Kwee Yong","doi":"10.1016/S2152-2650(24)01860-3","DOIUrl":"10.1016/S2152-2650(24)01860-3","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Page S13"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142311711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信